2,737
Views
8
CrossRef citations to date
0
Altmetric
Review Articles

Is the gap between micro- and macroeconomic assessments in health care well understood? The case of vaccination and potential remedies

&
Article: 23897 | Received 23 Jan 2014, Accepted 03 Jul 2014, Published online: 10 Apr 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Nikolaos Kotsopoulos, Gertruud Haitsma, Mark P. Connolly & Baudouin Standaert. (2020) Estimating the money flow in the economy attributed to rotavirus disease and vaccination in the Netherlands using a Social Accounting Matrix (SAM) framework. Expert Review of Pharmacoeconomics & Outcomes Research 20:6, pages 603-612.
Read now

Articles from other publishers (7)

Simon van der Schans, Marcel H. Schöttler, Jurjen van der Schans, Mark P. Connolly, Maarten J. Postma & Cornelis Boersma. (2023) Investing in the Prevention of Communicable Disease Outbreaks: Fiscal Health Modelling—The Tool of Choice for Assessing Public Finance Sustainability. Vaccines 11:4, pages 823.
Crossref
Faris El-Dahiyat, Daneh Obaid & Ghaleb El Refae. 2020. Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy. Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy 1 12 .
Ana T. Paquete, Rui Martins, Nikolaos Kotsopoulos, Michael Urbich, Colin Green & Mark P. Connolly. (2022) Fiscal consequences of Alzheimer's disease and informal care provision in the UK: A “government perspective” microsimulation. The Journal of the Economics of Ageing 23, pages 100413.
Crossref
Baudouin Standaert, Christophe Sauboin, Quentin J. Leclerc & Mark P. Connolly. (2020) Comparing the Analysis and Results of a Modified Social Accounting Matrix Framework with Conventional Methods of Reporting Indirect Non-Medical Costs. PharmacoEconomics 39:2, pages 257-269.
Crossref
Mark P. Connolly & Nikolaos Kotsopoulos. (2020) Estimating the Fiscal Consequences of National Immunization Programs Using a “Government Perspective” Public Economic Framework. Vaccines 8:3, pages 495.
Crossref
Mark P. Connolly, Saswat Panda, Julien Patris & Bouke P. C. Hazenberg. (2019) Estimating the fiscal impact of rare diseases using a public economic framework: a case study applied to hereditary transthyretin-mediated (hATTR) amyloidosis. Orphanet Journal of Rare Diseases 14:1.
Crossref
Mark Doherty, Philippe Buchy, Baudouin Standaert, Carlo Giaquinto & David Prado- Cohrs. (2016) Vaccine impact: Benefits for human health. Vaccine 34:52, pages 6707-6714.
Crossref